Duphalac and Oxaliplatin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Duphalac (lactulose) and Oxaliplatin (oxaliplatin). Common drug interactions include hypokalaemia among females and abdominal pain among males.
The phase IV clinical study analyzes what interactions people have when they take Duphalac and Oxaliplatin. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.
What is Duphalac?
Duphalac has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 5,152 Duphalac users. Check the latest studies of Duphalac.
What is Oxaliplatin?
Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.
49 people who take Duphalac and Oxaliplatin together, and have interactions are studied.

What are the common drug interactions of Duphalac and Oxaliplatin, by gender? *:
female:
- Hypokalaemia (low potassium)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
- Febrile neutropenia (fever with reduced white blood cells)
- Salivary hypersecretion (excess saliva secretion)
- Stomatitis (inflammation of mucous membrane of mouth)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Femoral neck fracture (neck of femur bone fracture)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Pyrexia (fever)
male:
- Abdominal pain
- Hepatotoxicity (chemical-driven liver damage)
- Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Dyspnoea at rest (difficult or laboured breathing during rest)
- Gastrointestinal perforation (hole in the digestive tract)
- Hepatic enzyme increased
- Hepatobiliary disease (diseases affect the liver and/or biliary tract)
- Hyperkalaemia (damage to or disease of the kidney)
- Hypotension (abnormally low blood pressure)
What are the common drug interactions of Duphalac and Oxaliplatin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Abdominal pain
- Lipase increased
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Hyperkalaemia (damage to or disease of the kidney)
- Nausea (feeling of having an urge to vomit)
- Vomiting
40-49:
- Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Pyrexia (fever)
- Thrombocytopenia (decrease of platelets in blood)
- Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
- Hepatotoxicity (chemical-driven liver damage)
- Ileal perforation
- Neoplasm malignant (cancer tumour)
50-59:
- Febrile neutropenia (fever with reduced white blood cells)
- Femoral neck fracture (neck of femur bone fracture)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Fall
- General physical health deterioration (weak health status)
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Thrombosis (formation of a blood clot inside a blood vessel)
- Coagulopathy (blood's ability to clot is impaired)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Femur fracture
60+:
- Hypokalaemia (low potassium)
- Salivary hypersecretion (excess saliva secretion)
- Altered state of consciousness (altered state of mind)
- Anaphylactic reaction (serious allergic reaction)
- Capillaritis (inflamed capillaries under the skin)
- Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
- Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
- Death
- Dyspnoea (difficult or laboured respiration)
- Dyspnoea at rest (difficult or laboured breathing during rest)
What are the existing conditions these people have? *
- Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 11 people, 22.45%
- Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 7 people, 14.29%
- Nausea (feeling of having an urge to vomit): 7 people, 14.29%
- Abdominal Pain: 6 people, 12.24%
- Diabetes: 6 people, 12.24%
- Adenocarcinoma Pancreas (cancer of pancreas): 5 people, 10.20%
- Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 5 people, 10.20%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 10.20%
- Itching: 5 people, 10.20%
- Indigestion: 5 people, 10.20%
* Approximation only. Some reports may have incomplete information.
Do you take Duphalac and Oxaliplatin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Duphalac (5,152 reports)
- Oxaliplatin (72,058 reports)
Browse all drug interactions of Duphalac and Oxaliplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Duphalac:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Oxaliplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Duphalac and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Oxaliplatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
- Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .
- Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
- Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on lactulose and oxaliplatin (the active ingredients of Duphalac and Oxaliplatin, respectively), and Duphalac and Oxaliplatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Aspirin cause Pressure Of Speech? - a second ago
- Hot Flush in Diphen, how severe and when it was recovered? - 7 seconds ago
- Oxycodone And Acetaminophen vs. Relafen, side effect and effectiveness comparison - 11 seconds ago
- Rickets and drugs of ingredients of drospirenone; ethinyl estradiol - 31 seconds ago
- Could Donepezil cause Erythema Multiforme? - 37 seconds ago
- Sitagliptin Phosphate and Heat Stroke for Men aged 60+ - 56 seconds ago
- Sitagliptin Phosphate and Body Overheating for Men aged 60+ - 56 seconds ago
- Sitagliptin Phosphate and Pyrexia for Men aged 60+ - 56 seconds ago
- Sitagliptin Phosphate and Hyperthermia for Men aged 60+ - 56 seconds ago
- Sitagliptin Phosphate and Elevated Temperature for Men aged 60+ - 57 seconds ago